Ischemia‐Modified albumin level in type 2 diabetes mellitus—Preliminary report
Open Access
- 1 January 2008
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 24 (6) , 311-317
Abstract
Aim: The main goal of the present study was the evaluation of ischemia‐modified albumin (IMA) in patients with type 2 diabetes mellitus and estimation of its connection with vascular complications, glycemic control, hypertension, dyslipidemia and obesity.Methods: In 76 diabetic patients and 25 control subjects, a plasma level of IMA by manually performed, spectrophotometric Co(II)‐albumin binding assay was determined. Other parameters such as glucose, fructosamine, HbA1c, total cholesterol and its fractions (HDL, LDL), triglicerydes were estimated by routine methods.Results: Diabetic patients had significantly higher level of IMA in comparison with control subjects. There were not significant differences between groups with various states of vascular complications although the lowest concentration of IMA was observed in patients with microangiopathy. Patients with poor glycemic control had higher IMA level in comparison with these with good glycemic control. Significant correlation was observed between IMA and HbA1c. Among the risk factors, only blood pressure and LDL showed a weak relationship with IMA level.Conclusions: Our results revealed, for the first time, higher level of IMA in diabetic patients which confirms that it may be of non‐cardiac origin. We can suggest that the albumin molecule in plasma of diabetic patients is modified in the chronic hypoxia conditions provoked mainly by hyperglycemia and oxidative stress in diabetes.Keywords
This publication has 25 references indexed in Scilit:
- AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitusDiabetes Research and Clinical Practice, 2007
- Evaluation of cardiac laboratory markers in patients with systemic sclerosisClinical Biochemistry, 2006
- Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albuminClinica Chimica Acta, 2006
- Albumin cobalt binding and ischemia modified albumin generation: An endogenous response to ischemia?International Journal of Cardiology, 2006
- Does hyperglycaemia precede the clinical onset of myocardial ischaemia?Resuscitation, 2005
- Release Characteristics of Cardiac Biomarkers and Ischemia-modified Albumin as Measured by the Albumin Cobalt-binding Test after a Marathon RaceClinical Chemistry, 2002
- Characteristics of an Albumin Cobalt Binding Test for Assessment of Acute Coronary Syndrome Patients: A Multicenter StudyClinical Chemistry, 2001
- A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary reportThe Journal of Emergency Medicine, 2000
- Glucose and free radicals impair the antioxidant properties of serum albuminThe FASEB Journal, 1999
- Reactive Oxygen-Mediated Protein Oxidation in Aging and DiseaseChemical Research in Toxicology, 1997